BWX Technologies, Inc. (BWXT) | The Buildout — AI Infrastructure

——Mkt cap — · 52-wk —–— · YTD — · delayed
Updated Sep 22, 2026Q2 FY2026 reviewed
BWX Technologies manufactures nuclear components, reactors and fuel for naval propulsion and commercial nuclear power.
Backlog $8.4B
Up 40% year over year; trailing book-to-bill 1.7x.
Revenue +18%
Q2 2026 revenue $902M, including 9% organic growth.
Commercial +33%
Q2 2026 organic Commercial revenue growth.
Margins compressing
Gross margin 22.4% in Q2, down from 25.1% a year earlier.
The Buildout Takeaway
BWXT sits behind the nuclear supply chain rather than in front of it. Data-center power demand strengthens the case for firm nuclear power, and BWXT supplies components and fuel into that — but management discloses no AI-attributable revenue and names no AI data-center project behind its backlog. The open question is timing: the new-build orders that would fill capacity BWXT is building ahead of demand are gated by government deal structures and by utilities that say they are waiting.
16 analysts·11 Buy4 Hold1 Sell
Coverage is thin — only 2 price estimates, so no target is shown

FY2026 guide: revenue ~$3.8B · adjusted EBITDA $662–672M · non-GAAP EPS $4.70–4.80 · free cash flow $345–360M.
Important: The Buildout is a data analytics platform. Content is generated by algorithms and AI agents using public filings, earnings transcripts, and market data. This is not personalized investment advice.
Our View

The Verdict

BWX Technologies makes the nuclear components, reactors and fuel that go into U.S. naval propulsion and commercial nuclear power. It is a supplier, not a reactor vendor — management describes it as a merchant supplier that sells into the reactor OEMs, the utilities and the government rather than building plants itself. For the AI buildout, that puts it one step back from the data center: the link runs through nuclear power demand, which data-center load growth helps pull forward, not through anything BWXT sells directly to AI. The company is narrowing to two cores, national security and commercial nuclear power, and is building U.S. commercial manufacturing capacity ahead of the orders it expects.

Market Cap—
Revenue (TTM)$3.5B
Revenue Growth+22.7%
EBITDA Margin (TTM)13.0%
Net Debt$1.4B
Earnings Beats7 of 7
P/E (TTM)—
EV/EBITDA (TTM)—

What We Like

  • Backlog was $8.4B at Q2 2026, up 40% year over year, with trailing 12-month book-to-bill of 1.7x.
  • Commercial Operations organic revenue grew 33% in Q2 2026 and 39% in Q1 2026; FY2026 Commercial revenue growth guidance was raised to about 45% from about 30%.
  • FY2026 guidance was raised at both the Q1 and Q2 calls: adjusted EBITDA to $662–672M, non-GAAP EPS to $4.70–4.80, and free cash flow to $345–360M.
  • Government Operations adjusted EBITDA margin is guided to about 20.5%, a 150 basis point increase from the start of the year that management attributes to cost performance.
  • Trailing-twelve-month free cash flow converts at 95% of net income, and Q2 2026 free cash flow was $115M.

What We’re Watching

  • Government Operations revenue growth guidance was cut to high single digits from low teens; management attributes it to favorable cost accounting, but the headline decelerates.
  • Backlog fell sequentially to $8.4B from $8.7B in Q1 2026 — management attributes it to the timing of large multiyear awards.
  • Commercial Operations margin was guided down to about 13% from about 14% on capacity and Canada investment; management expects a 2027 inflection.
  • The capacity being built is orders-agnostic — management says it is building in advance of the orders — and the validating new-build order is expected before year-end 2026.
Bottom Line

The demand thesis looks intact and, on the order book, strengthening: guidance was raised at both calls and backlog is up 40% year over year. The composition is less clean. Growth rates are decelerating off a step-change base, gross margin has compressed as mix shifts toward the lower-margin Commercial segment, and the demand the capacity is built to serve is gated by government deal structures and by utilities that describe new nuclear as early or not next. The open question is whether a commercial new-build order lands before year-end 2026.

Next upInvestor Day on September 29, 2026, in New York City is the next scheduled milestone, and management has flagged it as the venue for longer-term targets. Before year-end 2026, management expects to secure at least one new-build nuclear equipment order.
Last Quarter — Q2 FY2026

Earnings Beat

BWXT reported Q2 2026 revenue of $902M, up 18% year over year including 9% organic growth, at a 22.4% gross margin. Government Operations revenue rose 2% at a 20.9% adjusted EBITDA margin, while Commercial Operations revenue rose 72% total and 33% organic at an 11.9% margin. Backlog stood at $8.4B, up 40% year over year, with trailing 12-month book-to-bill of 1.7x.

MetricQ2 FY2026Q1 FY2026Q2 FY2025YoY
Revenue$902M$861M$764M+18.0%
Gross margin22.4%23.0%25.1%-270bps
EBITDA$121M$115M$130M−6.6%
EPS$0.97$0.99$0.85+13.2%
Backlog$8.4B$8.7Bn/a+40%
Book-to-bill (trailing 12-month)1.7xn/an/a—
We believe the industry is in the early stages of a multi-decade super cycle of growth.— Rex D. Geveden, President & CEO, 2026-08-03

Management tone: Management's framing escalated across the two calls in the source. The Q1 2026 call leaned on "record backlog, unprecedented demand"; by the Q2 call the language had hardened to structural, describing the industry as being in the early stages of a multi-decade super cycle and BWXT's role as a super merchant supplier for critical nuclear technologies. Management answered most analyst questions directly, including why no firm U.S. AP1000 order has been placed, and was candid about soft spots — calling nuclear project delivery the biggest risk in the market and saying the company was not yet ready to make a full capital commitment on TRISO.

Management Guidance

For FY2026, management guides revenue of approximately $3.8B, adjusted EBITDA of $662–672M, non-GAAP EPS of $4.70–4.80, and free cash flow of $345–360M, with capital expenditures at about 6% of sales. Two segment lines moved in opposite directions. Government Operations revenue growth was cut to high single digits from low teens while its margin was raised to about 20.5% from above 19% — management attributes the reversal to improved cost performance that lowers reported revenue under its accounting rules. Commercial Operations revenue growth was raised to about 45% from about 30%, with slightly more than half the increase from the PCG acquisition, while its margin was cut to about 13% from about 14% on U.S. capacity and Canada investment. No 2027 guidance was set.

Business Trajectory

Trajectory

Revenue grew 18% year over year in Q2 2026 to $902M, against 26% in Q1 2026. The mix is shifting toward the faster-growing, lower-margin Commercial segment: Commercial organic revenue rose 33% in Q2 and 39% in Q1, while Government Operations grew 2% in Q2. Government Operations ran a 20.9% adjusted EBITDA margin and Commercial Operations an 11.9% margin. Gross margin was 22.4% in Q2 2026, down from 25.1% a year earlier, and free cash flow was $115M.

Revenue & Margin Trajectory
RevenueGross margin$0$500$380M$404M$428M$410M$419M$430M$458M$439M$426M$478M$416M$471M$506M$501M$542M$504M$520M$557M$528M$505M$499M$592M$531M$554M$524M$624M$568M$612M$590M$726M$604M$682M$672M$746M$682M$764M$866M$886M$861M$902M28%22%Q3'16Q4Q1'17Q2Q3Q4Q1'18Q2Q3Q4Q1'19Q2Q3Q4Q1'20Q2Q3Q4Q1'21Q2Q3Q4Q1'22Q2Q3Q4Q1'23Q2Q3Q4Q1'24Q2Q3Q4Q1'25Q2Q3Q4Q1'26Q2
RevenueGross margin$0$500$380M$404M$428M$410M$419M$430M$458M$439M$426M$478M$416M$471M$506M$501M$542M$504M$520M$557M$528M$505M$499M$592M$531M$554M$524M$624M$568M$612M$590M$726M$604M$682M$672M$746M$682M$764M$866M$886M$861M$902M28%22%Q3'16Q4Q1'17Q2Q3Q4Q1'18Q2Q3Q4Q1'19Q2Q3Q4Q1'20Q2Q3Q4Q1'21Q2Q3Q4Q1'22Q2Q3Q4Q1'23Q2Q3Q4Q1'24Q2Q3Q4Q1'25Q2Q3Q4Q1'26Q2
Gross margin as reported.
Share Price — 12 Months
$100$200$052-wk high $238Sep '25DecMar '26JunSep '26
52-week range $146–$238.
Share Price — 12 Months
$100$200$052-wk high $238Sep '25DecMar '26JunSep '26
52-week range $146–$238.
The Numbers

The Model

The model projects FY+1 revenue of $3,815M and EBITDA of $673M, a 17.65% margin, and FY+2 revenue of $4,175M and EBITDA of $758M, an 18.15% margin. The near-term anchor is the FY2026 guidance range and an order book at roughly 2.2 years of revenue at the current run rate. FY+2 depends on Commercial Operations growth holding near its guided level, on HPDU and newer government programs ramping, and on whether new-build equipment orders begin to convert into backlog.

Revenue & EBITDA Projections
REVENUE$3.2B$3.8B$4.2BFY25FY+1 (E)FY+2 (E)EBITDA & MARGIN$472M$673M$758M18.1%FY25FY+1 (E)FY+2 (E)
REVENUE$3.2B$3.8B$4.2BFY25FY+1 (E)FY+2 (E)EBITDA & MARGIN$472M$673M$758M18.1%FY25FY+1 (E)FY+2 (E)
Solid bars are reported actuals; outlined bars are model projections — not company guidance.
MetricFY2025Next FY (E)Following FY (E)
Revenue$3.2B$3.8B$4.2B
YoY Growth—+19.3%+9.4%
EBITDA$472M$673M$758M
EBITDA Margin14.8%17.6%18.1%

Projections are the median of 4 independent model runs. The model’s revenue sits 1.7% above analyst consensus.

For FY2026, management guides revenue of approximately $3.8B, adjusted EBITDA of $662–672M, non-GAAP EPS of $4.70–4.80, and free cash flow of $345–360M, with capital expenditures at about 6% of sales. Two segment lines moved in opposite directions. Government Operations revenue growth was cut to high single digits from low teens while its margin was raised to about 20.5% from above 19% — management attributes the reversal to improved cost performance that lowers reported revenue under its accounting rules. Commercial Operations revenue growth was raised to about 45% from about 30%, with slightly more than half the increase from the PCG acquisition, while its margin was cut to about 13% from about 14% on U.S. capacity and Canada investment. No 2027 guidance was set.

What Could Go Right — and Wrong

What good looks like
  • At least one new-build nuclear equipment order is secured before year-end 2026, validating the commercial capacity investment.
  • A final investment decision on the U.S. commercial manufacturing site makes the largest visible capital commitment concrete.
  • Commercial Operations margin inflects in 2027 as capacity investment slows and PCG utilization rises from about 50%.
  • HPDU and newer government programs ramp into second-half 2026 revenue, and legacy-priced backlog burns off by end-2026, lifting Government margin.
  • A TRISO capital commitment follows the Janus selection, turning a market management calls highly uncertain into committed capacity.
What could go wrong
  • The year-end new-build order does not land, leaving capacity built ahead of demand with no near-term offset.
  • Backlog declines for a second consecutive quarter, turning award timing into a trend.
  • Commercial margin stays below guidance as capacity investment continues and PCG utilization ramps slowly.
  • New-build demand slips further as utilities keep waiting on government special-purpose-vehicle deal structures.
  • Consolidated margin compresses further as revenue mix shifts toward the lower-margin Commercial segment faster than Government execution gains offset it.
What’s Next

Looking Ahead

Over the next twelve months, the milestones management has set are specific: an Investor Day on September 29, 2026, at least one new-build nuclear equipment order before year-end 2026, a final investment decision on U.S. commercial capacity "in the coming months," an operational prototype centrifuge in 2026, and a meaningful HPDU contribution to second-half Government Operations revenue. The medical sale to Nordic Capital is also pending, with no close date specified.

Catalysts
  • September 29, 2026Investor Day — Longer-term targets and capital framework, in New York City.
  • Before year-end 2026New-build order — At least one new-build nuclear equipment order expected.
  • Coming monthsCapacity FID — Final investment decision on the U.S. commercial capacity site.
  • 2026Centrifuge prototype — Operational prototype centrifuge targeted for delivery this year.
  • H2 2026HPDU revenue ramp — New HPDU plants expected to lift Government Operations revenue.
  • Early 2030sCanada long-lead demand — Canadian large-reactor long-lead orders expected to reach BWXT.
Numbers

Financials

Annual Summary

MetricFY2024FY2025TTMYoY
Revenue$2.7B$3.2B$3.5B+18.3%
Gross Margin24.3%23.0%22.0%125bps
EBITDA$466M$472M$458M+1.2%
EBITDA Margin17.2%14.8%13.0%250bps
Net Income$282M$329M$355M+16.7%
Free Cash Flow$255M$295M$317M—
Net Cash————

Key Ratios (Trailing)

Valuation
  • P/E TTM—
  • EV/EBITDA TTM—
  • EV/Revenue TTM—
  • Price/FCF TTM—
Profitability
  • Gross Margin (TTM)22.0%
  • EBITDA Margin (TTM)13.0%
  • Net Margin (TTM)10.1%
  • ROIC9.8%
  • FCF Conversion69.2%
  • SBC / Revenue0.9%
Reference

The Company

BWX Technologies is, in its own filing language, "a specialty manufacturer of nuclear components, a developer of nuclear technologies and a service provider with an operating history of more than 100 years." Its core business is the design, engineering and manufacture of precision naval nuclear components, reactors and nuclear fuel for the U.S. Government, alongside special nuclear materials processing, products and services to the nuclear power industry and advanced nuclear technologies. It sells to the reactor OEMs, to utilities and to the government as a component, fuel and services supplier rather than as a reactor vendor — management describes it as a merchant supplier that participates across the nuclear value chain rather than betting on a single reactor design.

The company runs about 11,000 employees across two reporting segments. Government Operations manufacturing is U.S.-based and owned: Lynchburg, Virginia; Barberton and Euclid, Ohio; Mount Vernon, Indiana; and Erwin and Jonesborough, Tennessee. Commercial Operations manufacturing is concentrated in Canada, at Cambridge and Etobicoke, Ontario (owned) plus several leased Ontario and Vancouver sites. Net property, plant and equipment of $1,596M splits roughly 55% United States and 44% Canada. Management says the company has delivered 420 essentially small modular reactors over the last 50 years.

Business Segments

Government Operations
Guided to high single-digit FY2026 revenue growth at about a 20.5% margin
Precision naval nuclear components, reactors and nuclear fuel for the DOE/NNSA Naval Nuclear Propulsion Program.
Growth driver: Navy shipbuilding cadence; new special-materials programs
Commercial Operations
Guided to about 45% FY2026 revenue growth at about a 13% margin
Commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, fuel and services.
Growth driver: Commercial nuclear power demand; PCG in-sourcing

Competitive Landscape

The 10-K names competitors in both segments. In Government Operations: Bechtel National, Amentum Environment & Energy, Fluor, Northrop Grumman, Huntington Ingalls, Honeywell, Leidos, Westinghouse Electric and AtkinsRéalis. In Commercial Operations: Framatome, Cameco, Doosan Heavy Industries & Construction, AECON Group, Westinghouse Electric and AtkinsRéalis. On large components, management says its capabilities compare favorably with "the largest industrial players, the Doosans and the [NNSAs] of the world," and describes BWXT as "the last man standing in commercial capability in North America." Management says BWXT is the only producer of TRISO fuel at any scale, while noting TRISO X and Standard Nuclear among new entrants.

  • Westinghouse Electric
    Named in filings as a competitor in both segments. Management said it is "in touch with the top leadership" on AP1000 opportunities, making Westinghouse both a competitor and a potential customer.
  • Framatome
    Named in filings as a Commercial Operations competitor; also the Isogen joint venture partner, which is excluded from the medical sale.
  • Huntington Ingalls
    Named in filings as a Government Operations competitor; not discussed.
  • Fluor
    Named in filings as a Government Operations competitor; not discussed.
  • Doosan Heavy Industries & Construction
    Named in filings as a Commercial Operations competitor; management cites "the Doosans" among the large industrial players it compares favorably with.
Competitor names come from the FY2025 10-K (accession 0001486957-26-000007) and management commentary on the Q2 2026 call. Names appearing only in the wiring layer are unverified leads and are not listed here.

Supply Chain

BWXT buys specialty alloys and sells nuclear components, fuel and services into reactor OEMs, utilities and the U.S. Government. Its one verified supplier relationship is ATI, which supplies zirconium, nickel and titanium alloys under a five-year agreement through 2030.

Supplier
Zirconium, nickel and titanium alloys for fuel cladding and reactor components; five-year naval nuclear agreement through 2030
→
Only surviving large-component nuclear plant
BWXT
Designs and manufactures nuclear components, reactors and fuel across U.S. and Canadian plants.
→
U.S. Government
68% of FY2025 revenue
Navy/Naval Reactors, NNSA/DOE, U.S. Army/DIU
Large utility customers
63% of FY2025 Commercial revenue
Two customers were 61% of Q1 2026 Commercial revenue
GE Hitachi / Ontario Power Generation
Reactor vessel supplier on the first BWRX-300 SMR at Darlington

Analysis updated Sep 22, 2026, reviewing Q2 FY2026. Prices delayed. Built with The Buildout’s published methodology. Not investment advice. No positions held. © The Buildout 2026.

More on BWXT: Earnings recap